Home - St. Luke's Hospital
Letter from Dr. Van Amburg

Services at St. Luke's Center for Cancer Care

Cancer Center Ribbon Cutting Brings Hope to Patients and Staff

Summary by Body System and Best CS/AJCC Stage Report - PDF

Expanded Radiation Oncology Department Brings Upgrades for Center for Cancer Care

New Mammography Reporting and Tracking Systems Optimize Patient Care

Research Cures Cancer

The Cancer Resource Center: Meeting the Needs of Our Patients and the Community

St. Luke's Cancer Rehabilitation Program

Oncology Conferences Promote Knowledge and Learning in the St. Louis Community

St. Luke's Hospital 2013 Community Screening, Prevention and Education Programs

Focus on Quality: Gastrointestinal Cancer Treatment at St. Luke's Hospital

"This feels like home. It feels like they care and they want you to get better."

"I was not treated like a number, a case, a tumor. I was treated as a person who happened to have cancer."

Oncology Steering Committee - PDF



Back to Main Site
Research Cures Cancer
Research is the foundation for progress in cancer care. Our cancer clinical research team strives to understand the complexities of various forms of cancer in the effort to help develop new, viable treatment options. Promising new therapies or diagnostic approaches must be validated in real world conditions before they can be approved for general use.

Patients who participate in clinical trials are among the first to receive novel treatments before they become commonly available. As part of the process, patients are carefully screened for eligibility, including type of disease and its stage, as well as the participant's age and general health. Accepted eligibility criteria help assure trial results accurately answer the research question and identify individuals who will benefit from the approach studied. In addition, the clinical research team follows enrolled patients for up to 20 years after their treatment is complete. This allows researchers to assess both the short and long-term risks and benefits of the new therapy.

St. Luke's is proud to partner with well-respected local and national clinical trial groups including the National Cancer Institute (NCI). St. Luke's broad-based program of clinical research includes about 20 trials at any given time. We are an active participant in the Alliance for Clinical Trials in Oncology, through our affiliation with Washington University School of Medicine. We are able to access trials from the Eastern Cooperative Oncology Group, the Southwest Oncology Group and NRG Oncology (formerly known as the National Surgical Adjuvant Breast and Bowel Project) through our participation in the NCI Clinical Trial Support Unit. Currently, our medical oncologists, breast surgeons and radiation oncologists are active participants in this effort.

In addition to overseeing patients on protocol, we are responsible for complying with federal guidelines regarding patient safety, efficacy and privacy. This regulatory function involves the oversight of the St. Luke's Institutional Review Board during the initial protocol review, annual review and amendment process.

The St. Luke's oncology program was reviewed by the Commission on Cancer in 2013. Our cancer clinical research team was commended by the Commission for its outstanding number of clinical trial accruals.

"It is our hope that this team-based approach will accelerate the pace of medical progress against cancer," says Donald Busiek, MD, who serves as St. Luke's Oncology Principal Investigator responsible for overseeing the oncology research program. "Each patient's contribution will lead to better outcomes in the future."

Information regarding available clinical trials (including eligibility and treatment) can be found here or by calling the Oncology Research Office at 314-205-6936.

Center for Cancer Care | Home - St. Luke's Hospital

232 South Woods Mill Road - Chesterfield, MO 63017 - 314-434-1500
© St. Luke's Hospital
Website Privacy Policy | Website Terms and Conditions
Patient Notice of Privacy Policies - PDF